RenovoRx's TAMP™ technology delivers chemotherapy directly to tumors, reducing side effects and improving treatment efficacy.
With a projected 330% price increase, RenovoRx is gaining investor...
Bright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric disorders, such as healing the central nervous...
2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector.
Gene therapy and oncology are driving biotech...
Bright Minds Biosciences launches a Phase 2 trial for BMB-101, targeting drug-resistant epilepsy with high unmet needs.
The company trades at a $5M market cap,...
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies.
NurExone chose to base its...